Research-driven company on the microbiome and its impact on health

Metabogen provides commercial access to metagenome research and development, helping the industry to create next ta probiotics and pharmaceutical products, based on the microbiome. The company has built a platform that integrates top-of-the line metagenomic data analysis with strain identification and subsequent development as well as clinical programs, to ensure successful development of novel assets.

Phase: Alumni
Impact: The platform allows us to study the microbial composition and reveal key microbial community members in various conditions, and to study the microbiome-host interactions in order to develop means for microbiome modulation and targeting.